Related references
Note: Only part of the references are listed.Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjogrens syndrome
Maarten van der Kroef et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
Luca Richeldi et al.
LANCET RESPIRATORY MEDICINE (2020)
Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers
Andrew Leask
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Boris Hinz et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts
Tiago Carvalheiro et al.
RHEUMATOLOGY (2020)
Investigating the potential of LSKL peptide as a novel hypertrophic scar treatment
Xiangwen Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment
Casimiro Gerarduzzi et al.
CANCER RESEARCH (2020)
The Role of Matrix Gla Protein (MGP) in Vascular Calcification
Geir Bjorklund et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma
Pei-Suen Tsou et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis
Su-Jin Moon et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The Expression and Possible Functions of Tenascin-W During Development and Disease
Richard P. Tucker et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?
Marta Colletti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
Shaoqiang Cheng et al.
CANCER BIOLOGY & THERAPY (2019)
CCN proteins as potential actionable targets in scleroderma
Pauline Henrot et al.
EXPERIMENTAL DERMATOLOGY (2019)
Functional Vascular Tissue Engineering Inspired by Matricellular Proteins
Aneesh K. Ramaswamy et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature
M. R. Pokeerbux et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Integration of pro- and anti-angiogenic signals by endothelial cells
Shideh Kazerounian et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
The multiple functions and mechanisms of osteopontin
Mehmet Arif Icer et al.
CLINICAL BIOCHEMISTRY (2018)
Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis
Eleni Chouri et al.
JOURNAL OF AUTOIMMUNITY (2018)
Distinct domains in the matricellular protein Lonely heart are crucial for cardiac extracellular matrix formation and heart function in Drosophila
Barbara Rotstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-beta signaling
Miwa Kanaoka et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis
Tetsuo Toyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Cartilage oligomeric matrix protein: COMPopathies and beyond
Karen L. Posey et al.
MATRIX BIOLOGY (2018)
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Joanne E. Murphy-Ullrich et al.
MATRIX BIOLOGY (2018)
The WNT signaling pathways in wound healing and fibrosis
Olivier Burgy et al.
MATRIX BIOLOGY (2018)
Existing and novel biomarkers for precision medicine in systemic sclerosis
Peter J. Wermuth et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
The role of osteopontin in the progression of solid organ tumour
Hailin Zhao et al.
CELL DEATH & DISEASE (2018)
The matricellular protein CCN1 in tissue injury repair
Ki-Hyun Kim et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
The concept of the CCN protein family revisited: a centralized coordination network
Bernard Perbal
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Periostin: A Matricellular Protein with Multiple Functions in Cancer Development and Progression
Laura Gonzalez-Gonzalez et al.
FRONTIERS IN ONCOLOGY (2018)
The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
Takayoshi Shirasaki et al.
SCIENTIFIC REPORTS (2018)
Unraveling SSc Pathophysiology; The Myofibroblast
Arjan van Caam et al.
FRONTIERS IN IMMUNOLOGY (2018)
Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China
Shasha Hu et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Thrombospondins: A Role in Cardiovascular Disease
Dimitry A. Chistiakov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis
Takashi Yamashita et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
Elisabeth H. Vollmann et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Periostin in the pathogenesis of skin diseases
Hiroyuki Murota et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts
Xiaohong Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis
Katsunari Makino et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Periostin in Mature Stage Localized Scleroderrna
Min-Woo Kim et al.
ANNALS OF DERMATOLOGY (2017)
Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation
Casimiro Gerarduzzi et al.
JCI INSIGHT (2017)
SPARCL1 a novel player in cancer biology
Filippo Gagliardi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis
Lisa M. Rice et al.
RHEUMATOLOGY (2016)
Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization
Andrew J. Sawyer et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Periostin as a multifunctional modulator of the wound healing response
John T. Walker et al.
CELL AND TISSUE RESEARCH (2016)
Integrin-mediated regulation of epidermal wound functions
C. Michael DiPersio et al.
CELL AND TISSUE RESEARCH (2016)
Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data
Viktor Martyanov et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
COMP-assisted collagen secretion - a novel intracellular function required for fibrosis
Jan-Niklas Schulz et al.
JOURNAL OF CELL SCIENCE (2016)
Strategy for treatment of fibrosis in systemic sclerosis: Present and future
Koichi Yanaba
JOURNAL OF DERMATOLOGY (2016)
Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis
Dongtak Jeong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Canonical Wnt signaling in systemic sclerosis
Christina Bergmann et al.
LABORATORY INVESTIGATION (2016)
The role of the SIBLING, Bone Sialoprotein in skeletal biology - Contribution of mouse experimental genetics
Wafa Bouleftour et al.
MATRIX BIOLOGY (2016)
Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway
Ping Zhao et al.
ONCOLOGY RESEARCH (2016)
Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran
Hadi Poormoghim et al.
RHEUMATOLOGY INTERNATIONAL (2016)
High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis
Fumiko Tomiyama et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells
Qi Gao et al.
CELL DEATH & DISEASE (2016)
Tenascin-C drives persistence of organ fibrosis
Swati Bhattacharyya et al.
NATURE COMMUNICATIONS (2016)
A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth
Katrina Viloria et al.
SCIENTIFIC REPORTS (2016)
Biomarkers in Scleroderma: Progressing from Association to Clinical Utility
Colin Ligon et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Thrombospondin expression in myofibers stabilizes muscle membranes
Davy Vanhoutte et al.
ELIFE (2016)
Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors
Pei-Suen Tsou et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Cell surface receptors for CCN proteins
Lester F. Lau
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2016)
Blockade of CCN4 attenuates CCl4-induced liver fibrosis
Xiaofei Li et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Proangiogenic Properties of Thrombospondin-4
Santoshi Muppala et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Origin of fibrosing cells in systemic sclerosis
Sarah Ebmeier et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis
Ryosuke Saigusa et al.
EXPERIMENTAL DERMATOLOGY (2015)
Thrombospondin-1-dependent immune regulation by transforming growth factor-β2-exposed antigen-presenting cells
Fayaz Ahmad Mir et al.
IMMUNOLOGY (2015)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa M. Rice et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Serum Cyr61 is Associated With Clinical Disease Activity and Inflammation in Patients With Systemic Lupus Erythematosus
Jinpiao Lin et al.
MEDICINE (2015)
Registry of the Spanish Network for Systemic Sclerosis Survival, Prognostic Factors, and Causes of Death
C. P. Simeon-Aznar et al.
MEDICINE (2015)
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
Alsya J. Affandi et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Matrix remodeling in systemic sclerosis
Andrew Leask
SEMINARS IN IMMUNOPATHOLOGY (2015)
Cytokines in the immunopathology of systemic sclerosis
Jasmin Raja et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study
Roger Hesselstrand et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Tenascin-X: beyond the architectural function
Ulrich Valcourt et al.
CELL ADHESION & MIGRATION (2015)
A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
Lisa M. Rice et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Pathogenesis of systemic sclerosis
Debendra Pattanaik et al.
FRONTIERS IN IMMUNOLOGY (2015)
A functional analysis of Wnt inducible signalling pathway protein-1 (WISP-1/CCN4)
Sarah Stephens et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2015)
Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer
Bruce L. Riser et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2015)
MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis
Yisha Li et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2015)
Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN- γ - secreting T-cell Ratios in Bleomycin-treated Mice
Keunhee Oh et al.
IMMUNE NETWORK (2015)
Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice
J. D. Coombes et al.
GUT (2015)
Cardiac Myocyte-Derived Follistatin-Like 1 Prevents Renal Injury in a Subtotal Nephrectomy Model
Satoko Hayakawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27Kip1 via Skp2 and FOXO3a regulation
I. Haque et al.
ONCOGENE (2015)
Inhibition of Bone Morphogenetic Protein Signal Transduction Prevents the Medial Vascular Calcification Associated with Matrix Gla Protein Deficiency
Rajeev Malhotra et al.
PLOS ONE (2015)
A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis
Xu Shiwen et al.
PLOS ONE (2015)
Tenascin-C: Form versus function
Sean P. Giblin et al.
CELL ADHESION & MIGRATION (2015)
Signaling in fibrosis: TGF-beta, wNT, and YAP/TAZ converge
Bram Piersma et al.
FRONTIERS IN MEDICINE (2015)
Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9
Joanna Nikitorowicz-Buniak et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Remodelling the extracellular matrix in development and disease
Caroline Bonnans et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Transforming growth factor β-at the centre of systemic sclerosis
Robert Lafyatis
NATURE REVIEWS RHEUMATOLOGY (2014)
Matricellular proteins and biomaterials
Aaron H. Morris et al.
MATRIX BIOLOGY (2014)
Revisiting the matricellular concept
Joanne E. Murphy-Ullrich et al.
MATRIX BIOLOGY (2014)
Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: Interaction, regulation and role in chondrogenesis
Chitrangada Acharya et al.
MATRIX BIOLOGY (2014)
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling
Yonggang Ma et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Mortality and survival in systemic sclerosis: Systematic review and meta-analysis
Manuel Rubio-Rivas et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Recent Advances in Understanding the Pathogenesis of Scleroderma-Interstitial Lung Disease
Tanjina Akter et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis
Y. Yamaguchi et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey
Paul Arora et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Serum levels of tenascin-C in collagen diseases
Kuniko Inoue et al.
JOURNAL OF DERMATOLOGY (2013)
The myofibroblast matrix: implications for tissue repair and fibrosis
Franco Klingberg et al.
JOURNAL OF PATHOLOGY (2013)
Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family
Tarek Abd El Kader et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2013)
Increased Accumulation of Extracellular Thrombospondin-2 Due to Low Degradation Activity Stimulates Type I Collagen Expression in Scleroderma Fibroblasts
Ikko Kajihara et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3
Monique Brissett et al.
ARTHRITIS AND RHEUMATISM (2012)
Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload
Ella G. Frolova et al.
FASEB JOURNAL (2012)
Diverse biological functions of the SPARC family of proteins
Amy D. Bradshaw
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Collagen XII and XIV, New Partners of Cartilage Oligomeric Matrix Protein in the Skin Extracellular Matrix Suprastructure
Pallavi Agarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
How do tenascins influence the birth and life of a malignant cell?
Florence Brellier et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis
Minghua Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma
Lingli Yang et al.
PLOS ONE (2012)
Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease
Roger Hesselstrand et al.
RHEUMATOLOGY (2012)
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and-2
Patrick R. Lawler et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis
Amlie Dendooven et al.
BIOMARKERS (2011)
Association of osteopontin regulatory polymorphisms with systemic sclerosis
Nadia Barizzone et al.
HUMAN IMMUNOLOGY (2011)
Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth
Ellen Van Obberghen-Schilling et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Joon-Il Jun et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Egr-1 Induces a Profibrotic Injury/Repair Gene Program Associated with Systemic Sclerosis
Swati Bhattacharyya et al.
PLOS ONE (2011)
Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis
Dawei Li et al.
ARTHRITIS RESEARCH & THERAPY (2011)
The Thrombospondins
Josephine C. Adams et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
6th International Workshop on the CCN Family of Genes, Newcastle, Ireland, October 20-24, 2010 Abstracts
Laure Rittie et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2011)
Thrombospondin 1 is a key mediator of transforming growth factor beta-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism
Yunliang Chen et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Four-Gene Biomarker Predicts Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
G. Farina et al.
ARTHRITIS AND RHEUMATISM (2010)
Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis
Yoran Margaron et al.
BIOPHYSICAL CHEMISTRY (2010)
Thrombospondin-4 Regulates Vascular Inflammation and Atherogenesis
Ella G. Frolova et al.
CIRCULATION RESEARCH (2010)
Recent advances in pulmonary fibrosis: implications for scleroderma
Robert J. Homer et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Antagonistic Effect of the Matricellular Signaling Protein CCN3 on TGF-β- and Wnt-Mediated Fibrillinogenesis in Systemic Sclerosis and Marfan Syndrome
Raphael Lemaire et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Osteopontin in the development of systemic sclerosis-relation to disease activity and organ manifestation
Johan M. Lorenzen et al.
RHEUMATOLOGY (2010)
Pathogenesis of Pulmonary Fibrosis in Systemic Sclerosis: Lessons from Interstitial Lung Disease
Kristen L. Veraldi et al.
Current Rheumatology Reports (2010)
CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease
Bruce L. Riser et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?
Andrew Leask et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
Jeff S. Isenberg et al.
NATURE REVIEWS CANCER (2009)
Structure of thrombospondins
C. B. Carlson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
Akeila Bellahcene et al.
NATURE REVIEWS CANCER (2008)
COMP acts as a catalyst in collagen fibrillogenesis
Krisztina Halasz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Pravastatin inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats
Valrie Haydont et al.
CLINICAL CANCER RESEARCH (2007)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways
Jaspreet Pannu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Thomas A. Wynn
JOURNAL OF CLINICAL INVESTIGATION (2007)
Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis
C. A. Davies et al.
RHEUMATOLOGY (2006)
Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein
Diane Proudfoot et al.
NEPHROLOGY (2006)
Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma
Xiaodong Zhou et al.
ARTHRITIS AND RHEUMATISM (2006)
Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts
Giuseppina Farina et al.
MATRIX BIOLOGY (2006)
Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts
Humphrey Gardner et al.
ARTHRITIS AND RHEUMATISM (2006)
Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins
FH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma
M Dziadzio et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function
H Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression
C Bourgier et al.
GUT (2005)
Insights into the molecular mechanism of chronic fibrosis: The role of connective tissue growth factor in scleroderma
A Leask et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma
XD Zhou et al.
ARTHRITIS AND RHEUMATISM (2002)
Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition
JR Mao et al.
NATURE GENETICS (2002)
A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1
JC Adams et al.
JOURNAL OF CELL BIOLOGY (2001)
Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis
X Shi-Wen et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
